Takeda Pharmaceutical Company Limited
HETEROCYCLIC COMPOUND

Abstract:

The present invention provides a heterocyclic compound having a HDAC6 inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the description, or a salt thereof.